Literature DB >> 16395538

Optimized hormonal stimulation is critical for production of viable embryos and establishment of subsequent implantation.

Tao Tao1, Alfred Robichaud, Sylvie Nadeau, Rejean Savoie, Bernard Gallant, Rodney J Ouellette.   

Abstract

PURPOSE: To investigate the effects of follicle number and size at the time of hCG administration, and ovarian stimulation length on the outcome of in vitro fertilization and pregnancy rate.
METHODS: During the ovarian stimulation regimen, the follicular number and size were determined by transvaginal ultrasonographic examination. Ovulation was induced as early as three or more follicles were at least 16 mm in their greatest diameter.
RESULTS: The fertilization rates were significantly increased with the longer length of stimulation (10-12 days: 75.4% and 13-16 days: 83.2%). However, no significant differences in the chemical pregnancy, clinical pregnancy, and implantation rates were found between 10-12 days (53.7%, 43.9%, and 21.8%) and 13-16 days (50.0%, 43.8%, and 23.4%) of stimulation. There were no significant differences in fertilization and chemical pregnancy rates between two groups with > or = and <18 follicles in the ovaries on the day of hCG (human chorionic gonadotrophin) administration. However, the clinical pregnancy and implantation rates (47.2% and 26.0%) in the group with <18 follicles were significantly higher than those (33.3% and 15.5%) in the group with > or =18 follicles, respectively.
CONCLUSIONS: Excessive and rapid ovarian stimulation appears to decrease the survival of embryos at later stages after transfer. The advantage of prolonged stimulation may outweigh the potential adverse effects in some patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16395538      PMCID: PMC3455430          DOI: 10.1007/s10815-005-9005-1

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  19 in total

1.  Prolonged follicle stimulation decreases pregnancy rates after in vitro fertilization.

Authors:  L Clark; J Stanger; M Brinsmead
Journal:  Fertil Steril       Date:  1991-06       Impact factor: 7.329

2.  Follicular maturation parameters associated with the failure of oocyte retrieval, fertilization, and cleavage in vitro.

Authors:  Z Ben-Rafael; G S Kopf; L Blasco; G L Flickinger; R W Tureck; J F Strauss; L Mastroianni
Journal:  Fertil Steril       Date:  1986-01       Impact factor: 7.329

3.  Effect of ovarian stimulation with recombinant follicle-stimulating hormone, gonadotropin releasing hormone antagonists, and human chorionic gonadotropin on endometrial maturation on the day of oocyte pick-up.

Authors:  Efstratios Kolibianakis; Claire Bourgain; Carola Albano; Kaan Osmanagaoglu; Johan Smitz; Andre Van Steirteghem; Paul Devroey
Journal:  Fertil Steril       Date:  2002-11       Impact factor: 7.329

4.  Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial. The European Orgalutran Study Group.

Authors:  G Borm; B Mannaerts
Journal:  Hum Reprod       Date:  2000-07       Impact factor: 6.918

5.  Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation.

Authors:  M Fluker; J Grifo; A Leader; M Levy; D Meldrum; S J Muasher; J Rinehart; Z Rosenwaks; R T Scott; W Schoolcraft; D B Shapiro
Journal:  Fertil Steril       Date:  2001-01       Impact factor: 7.329

6.  Human ovarian steroid secretion in vivo: effects of GnRH agonist versus antagonist (cetrorelix).

Authors:  J A Garcia-Velasco; V Isaza; C Vidal; A Landazábal; J Remohí; C Simón; A Pellicer
Journal:  Hum Reprod       Date:  2001-12       Impact factor: 6.918

7.  Delaying human chorionic gonadotropin administration in human menopausal gonadotropin-induced cycles decreases successful in vitro fertilization of human oocytes.

Authors:  N Laufer; A H DeCherney; B C Tarlatzis; A L Zuckerman; M L Polan; A M Dlugi; R Graebe; E R Barnea; F Naftolin
Journal:  Fertil Steril       Date:  1984-08       Impact factor: 7.329

8.  Exposure to high levels of luteinizing hormone and estradiol in the early follicular phase of gonadotropin-releasing hormone antagonist cycles is associated with a reduced chance of pregnancy.

Authors:  Efstratios M Kolibianakis; Carola Albano; Jarl Kahn; Michel Camus; Herman Tournaye; Andre C Van Steirteghem; Paul Devroey
Journal:  Fertil Steril       Date:  2003-04       Impact factor: 7.329

9.  Three years of in vitro fertilization at Norfolk.

Authors:  H W Jones; A A Acosta; M C Andrews; J E Garcia; G S Jones; J Mayer; J S McDowell; Z Rosenwaks; B A Sandow; L L Veeck
Journal:  Fertil Steril       Date:  1984-12       Impact factor: 7.329

10.  Timing of nuclear progression and protein synthesis necessary for meiotic maturation of bovine oocytes.

Authors:  M A Sirard; H M Florman; M L Leibfried-Rutledge; F L Barnes; M L Sims; N L First
Journal:  Biol Reprod       Date:  1989-06       Impact factor: 4.285

View more
  2 in total

1.  Stimulation Duration in Patients with Early Oocyte Maturation Triggering Criteria Does Not Impact IVF-ICSI Outcomes.

Authors:  Sophie Stout; Yohann Dabi; Charlotte Dupont; Lise Selleret; Cyril Touboul; Nathalie Chabbert-Buffet; Emile Daraï; Emmanuelle Mathieu d'Argent; Kamila Kolanska
Journal:  J Clin Med       Date:  2022-04-22       Impact factor: 4.964

2.  Multilevel model to assess sources of variation in follicular growth close to the time of ovulation in women with normal fertility: a multicenter observational study.

Authors:  Rafael T Mikolajczyk; Joseph B Stanford; René Ecochard
Journal:  Reprod Biol Endocrinol       Date:  2008-12-10       Impact factor: 5.211

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.